BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma Research

ThinkCyte Expands Product Line to Advance Drug Discovery and Disease Research Innovation

ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will ...

January 28, 2025 | News

Azenta Life Sciences Powers UK Biocentre's Expansion with BioArc Ultra™ for Large-Scale Sample Storage

Azenta, Inc. (Nasdaq: AZTA) today announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale sample st...

January 27, 2025 | News

Novilytic Joins Forces with Avantor to Transform Drug Discovery with Proteometer® Platform

Novilytic, an innovator in molecular recognition technology, is proud to announce an exclusive distribution partnership with Avantor, a global supplier o...

January 23, 2025 | News

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Duke-NUS Celebrates 20 Years with Transformative Philanthropy, Securing Over S$30 Million for Medical Research and Education

The legacy of Duke-NUS' founding donor, the Estate of Khoo Teck Puat, continues with a transformative S$5.5 million gift towards research. The...

January 13, 2025 | News

Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development

In an exclusive interview with BioPharma APAC, Heather Hargett, Head of Cell Biology Reagents & Tools at MilliporeSigma ( Merck KGaA, Darmstadt, German...

January 10, 2025 | News

I-Mab Prioritizes Lead Program Givastomig to Advance Precision Immuno-Oncology for Gastric Cancer

Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody, will be the lead clinical program following the Company's portfolio prioritization ...

January 07, 2025 | News

GeneX India Bioscience Joins Forces with New England Biolabs to Advance Life Sciences Innovation in India

GeneX India Bioscience Pvt Ltd, a trusted name in providing life sciences solutions, proudly announces its official partnership with New England Bi...

January 02, 2025 | News

Exicure Signs MOU to Acquire GPCR USA and Advance Collaborative Research in Drug Development

Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with GPCR ...

December 30, 2024 | News

10x Genomics Secures Permanent Injunction Against Bruker’s GeoMx Products Following Patent Infringement Verdict

10x Genomics, Inc. , a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for...

December 24, 2024 | News

Porton Pharma and Dragon Sail Pharmaceutical Forge Strategic Alliance to Advance ADC Drug Development

Porton Pharma Solutions (hereinafter referred to as "company" or "Porton") and Dragon Sail Pharmaceutical (Shanghai) Co., Ltd. (a subsidiary of Guilin Sanj...

December 24, 2024 | News

SCG Cell Therapy Partners with A*STAR BTI and NATi to Accelerate RNA-Based Therapeutics Development and Commercialization

SCG Cell Therapy signed a Memorandum of Understanding (MoU) with A*STAR Bioprocessing Technology Institute (A*STAR BTI) and Nucleic Acid Therapeutics Ini...

December 23, 2024 | News

BGM Group Strengthens Strategic Partnership with Jointown Pharmaceutical Group

BGM Group Ltd. (NASDAQ: BGM) ("the Company" or "BGM"), Mr. Xin Zhanchang, Chairman of the Board of Directors of BGM Group and Chairman of Gansu Qilian...

December 20, 2024 | News

Stay Connected